National Genomic Test Directories

Document first published:
Page updated:
Topic:
, ,
Publication type:

From October 2018 the National Genomic Test Directory will specify which genomic tests are commissioned by the NHS in England, the technology by which they are available, and the patients who will be eligible to access to a test. The final draft 2018/2019 National Genomic Test Directory for rare and inherited disorders and cancer can be accessed below.

Summary

Rare and inherited disease – the National Genomic Test Directory for rare and inherited disorders specifies the genomic tests commissioned by the NHS in England for rare and inherited disorders from October 2018, the technology by which they are available, and the patients who will be eligible to access to a test. Please note this is a final draft and is not operational until October 2018.

Summary

Cancer – the National Genomic Test Directory for cancer specifies the genomic tests commissioned by the NHS in England for cancer from October 2018, the technology by which they are available, and the patients who will be eligible to access to a test. Please note this is a final draft and is not operational until October 2018.

Summary

Frequently asked questions about the development process and operation of the National Genomic Test Directory, and its context within the NHS Genomic Medicine Service.